Skip to main content

Advertisement

Table 3 Vital Signs and Blood Lipid Data

From: Twelve weeks supplementation with an extended-release caffeine and ATP-enhancing supplement may improve body composition without affecting hematology in resistance-trained men

Variable Treatment PRE Week 8 POST Reference Interval p
Systolic BP (mm Hg) PLA 127 ± 12.0 126.0 ± 12.2 127.0 ± 12.2 90–120 0.93
TRT 127.6 ± 12.8 127.7 ± 8.7 128.0 ± 10.4
Diastolic BP (mm Hg) PLA 76.1 ± 9.4 77.0 ± 8.0 76.4 ± 9.4 60–80 0.20
TRT 76.6 ± 8.1 74.2 ± 9.4 78.2 ± 8.6
Heart Rate (BPM) PLA 68.9 ± 10.6 70.1 ± 10.1 70.0 ± 7.7 <100 0.43
TRT 58.9 ± 12.0 62.1 ± 9.7 64.9 ± 9.4
Total Cholesterol (mg/dL) PLA 175.9 ± 41.9 175.1 ± 43.2 172.8 ± 41.0 100–199 0.39
TRT 161.2 ± 19.4 173.1 ± 22.3 164.2 ± 29.3
Triglycerides (mg/dL) PLA 109.7 ± 53.0 81.4 ± 37.9 89.5 ± 33.3 0–149 0.055
TRT 65.9 ± 22.2 74.5 ± 33.4 69.3 ± 36.5
High Density Lipoprotein (mg/dL) PLA 50.1 ± 13.3 47.6 ± 12.6 48.5 ± 11.2 >39 0.38
TRT 53.8 ± 6.4 54.2 ± 10.2 50.8 ± 8.2
Very Low Density Lipoprotein (mg/dL) PLA 21.9 ± 10.5 16.3 ± 7.6 18.0 ± 6.8 5–40 0.06
TRT 13.3 ± 4.5 15.0 ± 6.8 13.8 ± 7.3
Low Density Lipoprotein (mg/dL) PLA 103.9 ± 31.7 111.2 ± 31.2 106.4 ± 31.0 0–99 0.89
TRT 94.1 ± 18.8 103.9 ± 19.9 99.7 ± 24.4
  1. Data are presented as mean ± standard deviation. The p-value is derived from an ANOVA and representative of a main effect for group by time